Browse by Title

78 items found

Showing titles from 50 to 75:

  1  2  3  4   
FormatDateTitleAuthor
FormatDateTitleAuthor
doc icon DUGiDocs 2011 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux¬ģ) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrar√≥s, Cristina ; V√°zquez Mart√≠n, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cuf√≠ Gonz√°lez, S√≠lvia ; Hern√°ndez Yag√ľe, Xavier ; Guarde√Īo, Raquel ; B√°ez, Luciana ; Martin Castillo, Bego√Īa ; P√©rez Mart√≠nez, Maria Carmen ; L√≥pez Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernad√≥, Luis ; Brunet i Vidal, Joan ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux¬ģ) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrar√≥s, Cristina ; V√°zquez Mart√≠n, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cuf√≠ Gonz√°lez, S√≠lvia ; Hern√°ndez Yag√ľe, Xavier ; Guarde√Īo, Raquel ; B√°ez, Luciana ; Martin Castillo, Bego√Īa ; P√©rez Mart√≠nez, Maria Carmen ; L√≥pez Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernad√≥, Luis ; Brunet i Vidal, Joan ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux¬ģ) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrar√≥s, Cristina ; V√°zquez Mart√≠n, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cuf√≠ Gonz√°lez, S√≠lvia ; Hern√°ndez Yag√ľe, Xavier ; Guarde√Īo, Raquel ; B√°ez, Luciana ; Martin Castillo, Bego√Īa ; P√©rez Mart√≠nez, Maria Carmen ; L√≥pez Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernad√≥, Luis ; Brunet i Vidal, Joan ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat 2018 June 5 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux¬ģ) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrar√≥s, Cristina ; V√°zquez Mart√≠n, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cuf√≠ Gonz√°lez, S√≠lvia ; Hern√°ndez Yag√ľe, Xavier ; Guarde√Īo, Raquel ; B√°ez, Luciana ; Martin Castillo, Bego√Īa ; P√©rez Mart√≠nez, Maria Carmen ; L√≥pez Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernad√≥, Luis ; Brunet i Vidal, Joan ; Men√©ndez Men√©ndez, Javier Abel
doc icon TDX 2013 June 21 Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de càncer de mama (Basal/ErbB2+) Oliveras Ferrarós, Cristina
out url icon Recercat Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de càncer de mama (Basal/ErbB2+) Oliveras Ferrarós, Cristina
doc icon DUGiDocs 2015 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuy√†s, Elisabet ; Fern√°ndez Arroyo, Salvador ; Corominas Faja, Bruna ; Rodr√≠guez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Bego√Īa ; Llorens Duran, Rafael de ; Joven, Jorge ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuy√†s, Elisabet ; Fern√°ndez Arroyo, Salvador ; Corominas Faja, Bruna ; Rodr√≠guez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Bego√Īa ; Llorens Duran, Rafael de ; Joven, Jorge ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuy√†s, Elisabet ; Fern√°ndez Arroyo, Salvador ; Corominas Faja, Bruna ; Rodr√≠guez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Bego√Īa ; Llorens Duran, Rafael de ; Joven, Jorge ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat 2018 June 5 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuy√†s, Elisabet ; Fern√°ndez Arroyo, Salvador ; Corominas Faja, Bruna ; Rodr√≠guez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Bego√Īa ; Llorens Duran, Rafael de ; Joven, Jorge ; Men√©ndez Men√©ndez, Javier Abel
doc icon DUGiDocs 2017 June Paper jugat pel receptor ErbB-3 (HER-3) en el desenvolupament i tractament del càncer Cortés i Andrés, Adrià
out url icon Recercat Paper jugat pel receptor ErbB-3 (HER-3) en el desenvolupament i tractament del càncer Cortés i Andrés, Adrià
doc icon TDX 1994 December 16 Purificació, caracterització i clonatge de la ribonucleasa de pàncreas humà Ribó i Panosa, Marc
out url icon Recercat Purificació, caracterització i clonatge de la ribonucleasa de pàncreas humà Ribó i Panosa, Marc
doc icon DUGiDocs 2008 Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2016 September 12 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuy√†s, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Bego√Īa ; Brunet i Vidal, Joan ; Salazar, Ramon ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuy√†s, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Bego√Īa ; Brunet i Vidal, Joan ; Salazar, Ramon ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuy√†s, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Bego√Īa ; Brunet i Vidal, Joan ; Salazar, Ramon ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat 2018 June 5 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuy√†s, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Bego√Īa ; Brunet i Vidal, Joan ; Salazar, Ramon ; Men√©ndez Men√©ndez, Javier Abel
doc icon DUGiDocs 2012 Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrar√≥s, Cristina ; Massaguer i Vall-llovera, Anna ; V√°zquez Mart√≠n, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cuf√≠ Gonz√°lez, S√≠lvia ; Martin Castillo, Bego√Īa ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrar√≥s, Cristina ; Massaguer i Vall-llovera, Anna ; V√°zquez Mart√≠n, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cuf√≠ Gonz√°lez, S√≠lvia ; Martin Castillo, Bego√Īa ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Men√©ndez Men√©ndez, Javier Abel
out url icon Recercat Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrar√≥s, Cristina ; Massaguer i Vall-llovera, Anna ; V√°zquez Mart√≠n, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cuf√≠ Gonz√°lez, S√≠lvia ; Martin Castillo, Bego√Īa ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Men√©ndez Men√©ndez, Javier Abel
  1  2  3  4   

Subjects

Authors